Sort
51,593 grants matching “hepatitis”
CENTER FOR GASTROINTESTINAL BIOLOGY AND DISEASE
$969,828Robert S Sandler · Univ Of North Carolina Chapel Hill · P30 · FY2009 · DK
CENTER FOR GASTROINTESTINAL BIOLOGY AND DISEASE
$969,828Robert S Sandler · Univ Of North Carolina Chapel Hill · P30 · FY2008 · DK
Fibrogenesis Targeted Manganese Based MRI Contrast Agent
$969,394Vera Hoffman · Reveal Pharma · R44 · FY2024 · DK
Mechanisms of Therapy and Model Development in Viral Hepatitis and Liver Diseases
$969,213T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Appalachian Node
$969,141Jane M Liebschutz · University Of Pittsburgh At Pittsburgh · UG1 · FY2023 · DA
Structural studies of native-like SOSIP trimers
$968,906Ian A Wilson · Weill Medical Coll Of Cornell Univ · P01 · FY2017 · AI
Immunology of Acute and Chronic Viral Hepatitis
$968,816Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Acute Hepatitis C Infection in Young Injectors
$968,688Kimberly Page · University Of California, San Francisco · R01 · FY2010 · DA
Integrated University of Puerto Rico Clinical Trials Unit
$968,581Carmen D Zorrilla · University Of Puerto Rico Med Sciences · UM1 · FY2015 · AI
Development of two simple and robust point-of-care assays for detection and therapy monitoring of hepatitis B in resource-limited settings
$968,003Helen H Lee · Diagnostics For The Real World, Ltd · R44 · FY2017 · AI
Liver fibrosis cell-based assay platform: integrating patient-derived fibrotic liver ECM with primary stellate cells, Kupffer cells, and hepatocytes to accelerate anti-fibrotic drug development
$967,715John David O'Neill · Xylyx Bio, Inc. · R44 · FY2025 · DK
Profiling the protective B cell response to HCV
$966,661Steven Foung · Stanford University · U19 · FY2019 · AI
Optimizing eCD4-Ig for eradication and a functional cure
$966,508Michael R. Farzan · Scripps Florida · R01 · FY2017 · AI
Liver Center
$966,014University Of California San Francisco · P30 · FY2003 · DK
Structure-guided vaccine design of HCV E1E2 to induce broadly neutralizing antibodies (bNAbs)
$965,967Steven Foung · Stanford University · U19 · FY2023 · AI
Therapeutic Development of RNAi-based inhibitors against the Hepatitis Delta Virus
$965,488Brian H. Johnston · Somagenics, Inc. · R44 · FY2020 · AI
Hepatocyte Transplantation for Liver Based Metabolic Disease
$965,154Ira J. Fox · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · DK
Mechanisms of Alcoholic Liver Disease
$964,607Bin Gao · National Institute On Alcohol Abuse And Alcoholism · Z01 · FY2008 · AA
A randomised study of interferon-free treatment for recently acquired hepatitis C in people who inject drugs and people with HIV coinfection (the REACT Study)
$964,605Gail Matthews · University Of New South Wales · R01 · FY2018 · DA
Preclinical and clinical studies of an HBV rapid test for FDA Pre-market approval
$964,487Helen H Lee · Diagnostics For The Real World, Ltd · R44 · FY2007 · HL
Early detection of HCC using noninvasive activity-based nanosensors
$964,382Wendy Winckler · Glympse Bio, Inc. · R44 · FY2021 · CA
Colorado Center for Childhood Liver Disease Research and Education
$964,258Ronald J Sokol · University Of Colorado Denver · U01 · FY2013 · DK
Commercialization of Image-Guided Liver Surgery
$963,867James David Stefansic · Pathfinder Therapeutics · R44 · FY2007 · CA
RECOMBINANT AAV FOR CORRECTION OF GENETIC ABNORMALITIES
$963,786University Of Florida · P01 · FY2001 · DK
Individual, Network and Spatial Drivers of HIV and HCV among PWID in India
$963,776Sunil Suhas Solomon · Johns Hopkins University · R01 · FY2017 · DA